Guest guest Posted November 16, 2001 Report Share Posted November 16, 2001 From ASH. Some work has gone into VEGF (a blood vessel growth promoter) in CLL. There are several studies which show that angiogenesis is a factor in CLL. Yet high levels of VEGF are actually associated with prolonged survival. Here's more on VEGF: [4865] Receptors for Vascular Endothelial Growth Factor (VEGF) Are Expressed on B-chronic lymphocytic leukemia (CLL) Cells Osnat Bairey, Yael Zimra, Esther Rabizadeh, Mati Shaklai. Institute of Hematology and the Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel VEGF is a glycoprotein that induces the proliferation and migration of vascular endothelial cells. Until recently, VEGF receptors were thought to be exclusively expressed by adult endothelial cells and to exert their proangiogenic effect by way of paracrine mechanisms. Recently, however, it was shown that these receptors are present on a subset of hematopoietic stem cells, and on acute leukemia cells and cell lines. Since VEGF is also produced by leukemic cells including CLL cells, coinciding expression of VEGF receptors may result in the generation of an autocrine loop that supports the proliferation and survival of leukemic cells. We determined the percentage of cells expressing VEGF receptors in samples from B-CLL patients. We determined VEGF receptors expression on cells isolated from blood from 13 CLL patients. All the samples expressed VEGF receptors with a mean of CD19+/VEGF+ expression of 76% (range 52-92). Thus, in CLL the leukemic cells express VEGF receptors which may promote leukemic cell survival through an autocrine loop. __________________________________________________ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.